COURTNEY NURMI: Open Payments
NPI 1366095184 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$409 in 24 payments from 10 companies in 2025. Trend: 2023 $1,619 · 2024 $994 · 2025 $409
Food & beverage: $409
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $96 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $67 |
| PFIZER INC. | 4 | $65 |
| SCPHARMACEUTICALS INC. | 3 | $49 |
| Novartis Pharmaceuticals Corporation | 3 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Cranial Technologies, Inc | 1 | $18 |
| Novo Nordisk Inc | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: REPATHA, ELIQUIS, LifeVest, FUROSCIX, LEQVIO, JARDIANCE, ENTRESTO, Doc Band.
Industry payments across TX — which companies pay providers there.
